These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 19324842)
1. Anti-inflammatory and antioxidant effects of SERPINA3K in the retina. Zhang B; Hu Y; Ma JX Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3943-52. PubMed ID: 19324842 [TBL] [Abstract][Full Text] [Related]
2. Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor. Zhang SX; Wang JJ; Gao G; Shao C; Mott R; Ma JX FASEB J; 2006 Feb; 20(2):323-5. PubMed ID: 16368716 [TBL] [Abstract][Full Text] [Related]
4. Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2-induced intravitreal neovascularization in a rat model of retinopathy of prematurity. Wang H; Yang Z; Jiang Y; Hartnett ME Mol Vis; 2014; 20():231-41. PubMed ID: 24623966 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy. Deng G; Moran EP; Cheng R; Matlock G; Zhou K; Moran D; Chen D; Yu Q; Ma JX Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5030-5042. PubMed ID: 28979999 [TBL] [Abstract][Full Text] [Related]
6. Antioxidant-Rich Extract from Plantaginis Semen Ameliorates Diabetic Retinal Injury in a Streptozotocin-Induced Diabetic Rat Model. Tzeng TF; Liu WY; Liou SS; Hong TY; Liu IM Nutrients; 2016 Sep; 8(9):. PubMed ID: 27649243 [TBL] [Abstract][Full Text] [Related]
7. VEGF164 is proinflammatory in the diabetic retina. Ishida S; Usui T; Yamashiro K; Kaji Y; Ahmed E; Carrasquillo KG; Amano S; Hida T; Oguchi Y; Adamis AP Invest Ophthalmol Vis Sci; 2003 May; 44(5):2155-62. PubMed ID: 12714656 [TBL] [Abstract][Full Text] [Related]
8. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model. Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of connective tissue growth factor overexpression in diabetic retinopathy by SERPINA3K via blocking the WNT/beta-catenin pathway. Zhang B; Zhou KK; Ma JX Diabetes; 2010 Jul; 59(7):1809-16. PubMed ID: 20299474 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic potential of elema-1,3,7(11),8-tetraen-8,12-lactam from Curcuma wenyujin on diabetic retinopathy via anti-inflammatory and anti-angiogenic pathways. Cai Y; Tu H; Wu C; Liu T; Chen S; Shen L; Xiao Q; Zhao S; Xu S; Lin W; Yan P; Dong J J Ethnopharmacol; 2024 Jan; 318(Pt A):116843. PubMed ID: 37414197 [TBL] [Abstract][Full Text] [Related]
11. Protective effect of perindopril on diabetic retinopathy is associated with decreased vascular endothelial growth factor-to-pigment epithelium-derived factor ratio: involvement of a mitochondria-reactive oxygen species pathway. Zheng Z; Chen H; Ke G; Fan Y; Zou H; Sun X; Gu Q; Xu X; Ho PC Diabetes; 2009 Apr; 58(4):954-64. PubMed ID: 19188429 [TBL] [Abstract][Full Text] [Related]
12. Kallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakage. Gao G; Shao C; Zhang SX; Dudley A; Fant J; Ma JX Diabetologia; 2003 May; 46(5):689-98. PubMed ID: 12743698 [TBL] [Abstract][Full Text] [Related]
13. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response. Cui B; Sun JH; Xiang FF; Liu L; Li WJ Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442 [TBL] [Abstract][Full Text] [Related]
14. Protective and antioxidant effects of PPARα in the ischemic retina. Moran E; Ding L; Wang Z; Cheng R; Chen Q; Moore R; Takahashi Y; Ma JX Invest Ophthalmol Vis Sci; 2014 May; 55(7):4568-76. PubMed ID: 24825105 [TBL] [Abstract][Full Text] [Related]
15. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade. Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470 [TBL] [Abstract][Full Text] [Related]
16. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina. Masuzawa K; Goto K; Jesmin S; Maeda S; Miyauchi T; Kaji Y; Oshika T; Hori S Curr Eye Res; 2006 Jan; 31(1):79-89. PubMed ID: 16421022 [TBL] [Abstract][Full Text] [Related]
17. Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration. Qiu F; Meng T; Chen Q; Zhou K; Shao Y; Matlock G; Ma X; Wu W; Du Y; Wang X; Deng G; Ma JX; Xu Q Mol Pharm; 2019 May; 16(5):1958-1970. PubMed ID: 30912953 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of a monoclonal antibody blocking the Wnt pathway in diabetic retinopathy. Lee K; Hu Y; Ding L; Chen Y; Takahashi Y; Mott R; Ma JX Diabetes; 2012 Nov; 61(11):2948-57. PubMed ID: 22891217 [TBL] [Abstract][Full Text] [Related]
19. Ebselen by modulating oxidative stress improves hypoxia-induced macroglial Müller cell and vascular injury in the retina. Tan SM; Deliyanti D; Figgett WA; Talia DM; de Haan JB; Wilkinson-Berka JL Exp Eye Res; 2015 Jul; 136():1-8. PubMed ID: 25912997 [TBL] [Abstract][Full Text] [Related]
20. Hesperidin prevents retinal and plasma abnormalities in streptozotocin-induced diabetic rats. Shi X; Liao S; Mi H; Guo C; Qi D; Li F; Zhang C; Yang Z Molecules; 2012 Nov; 17(11):12868-81. PubMed ID: 23117428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]